The 8th China Vascular Congress (CVC 2023) was grand opened in Xi'an, the ancient capital of the millennium, from September 21 to September 24. Adhering to the concept of "Innovation, Transformation and Cooperation" and with the theme of "Smooth Blood Vessels and Long River of Life", this conference aims to promote the development of medical cause of vascular diseases in China, break disciplinary barriers and expand international vision. This conference has once again received extensive attention from industry experts and colleagues in the industry!

Recently, the innovative three branch stent system (CS stent) for the aorta, created by China and with full intellectual property rights, successfully completed its first application in Stanford B-type aortic dissection at Xiangya Second Hospital of Central South University. This innovative stent system provides a new solution for the full lumen treatment of Stanford B-type aortic dissection lesions involving the aortic arch, greatly optimizing the brain protection strategy for full lumen repair of the aortic arch in design, and is expected to help more patients avoid the huge trauma of thoracotomy surgery and significantly improve their quality of life.

On July 6, 2023, the 2022 China Hospital/Chinese Medical College Science and Technology Value (STEM) was released in a significant manner. Fuwai Hospital of the Chinese Academy of Medical Sciences (hereinafter referred to as "Fuwai Hospital") has been ranked first on the annual discipline list in Cardiology and Cardiovascular Surgery for the ninth consecutive year.